These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33867442)

  • 1. Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease.
    Shi H; Mao L; Wang L; Quan X; Xu X; Cheng Y; Zhu S; Dai F
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e535-e539. PubMed ID: 33867442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
    Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
    Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged orocecal transit time enhances serum bile acids through bacterial overgrowth, contributing factor to gallstone disease.
    Kaur J; Rana SV; Gupta R; Gupta V; Sharma SK; Dhawan DK
    J Clin Gastroenterol; 2014 Apr; 48(4):365-9. PubMed ID: 24598592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS.
    GuimarÃes VM; Santos VN; Borges PSA; DE Farias JLR; Grillo P; Parise ER
    Arq Gastroenterol; 2020; 57(4):471-476. PubMed ID: 33331479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients.
    Resmini E; Parodi A; Savarino V; Greco A; Rebora A; Minuto F; Ferone D
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2119-24. PubMed ID: 17405840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease.
    Rana SV; Sharma S; Malik A; Kaur J; Prasad KK; Sinha SK; Singh K
    Dig Dis Sci; 2013 Sep; 58(9):2594-8. PubMed ID: 23649377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India.
    Rana S; Bhansali A; Bhadada S; Sharma S; Kaur J; Singh K
    Diabetes Technol Ther; 2011 Nov; 13(11):1115-20. PubMed ID: 21770765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO.
    Jirapinyo P; Makuvire TT; Dong WY; Chan WW; Thompson CC
    Obes Surg; 2019 Mar; 29(3):771-775. PubMed ID: 30627990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased orocecal transit time in patients with nonalcoholic fatty liver disease.
    Soza A; Riquelme A; González R; Alvarez M; Pérez-Ayuso RM; Glasinovic JC; Arrese M
    Dig Dis Sci; 2005 Jun; 50(6):1136-40. PubMed ID: 15986870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.
    Fitriakusumah Y; Lesmana CRA; Bastian WP; Jasirwan COM; Hasan I; Simadibrata M; Kurniawan J; Sulaiman AS; Gani RA
    BMC Gastroenterol; 2019 Mar; 19(1):43. PubMed ID: 30894137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
    Belei O; Olariu L; Dobrescu A; Marcovici T; Marginean O
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1161-1168. PubMed ID: 28988228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome.
    Ding XW; Liu YX; Fang XC; Liu K; Wei YY; Shan MH
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5191-5196. PubMed ID: 29228433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children.
    Stepanov YM; Zavhorodnia NY; Yagmur VB; Lukianenko OY; Zygalo EV
    Wiad Lek; 2019; 72(3):350-356. PubMed ID: 31050979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth.
    Rafiei R; Bemanian M; Rafiei F; Bahrami M; Fooladi L; Ebrahimi G; Hemmat A; Torabi Z
    Rom J Intern Med; 2018 Jun; 56(2):85-89. PubMed ID: 29101772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
    Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
    Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy.
    Lunia MK; Sharma BC; Sachdeva S
    Hepatol Int; 2013 Mar; 7(1):268-73. PubMed ID: 26201641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon.
    Tursi A; Brandimarte G; Giorgetti GM; Elisei W
    Dig Dis Sci; 2006 Mar; 51(3):461-5. PubMed ID: 16614952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed small intestinal transit in patients with long-standing type 1 diabetes mellitus: investigation of the relationships with clinical features, gastric emptying, psychological distress, and nutritional parameters.
    Faria M; Pavin EJ; Parisi MC; Lorena SL; Brunetto SQ; Ramos CD; Pavan CR; Mesquita MA
    Diabetes Technol Ther; 2013 Jan; 15(1):32-8. PubMed ID: 23126582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.